Novel Insights to Enhance Therapeutics With Acyclovir in the Management of Herpes Simplex Encephalitis

Bilosomes nanocarriers for improved oral bioavailability of acyclovir: A complete characterization through in vitro, ex-vivo and in vivo assessment

(2020) Zoya Saifi Rizwanullah et al.   JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY

Intravenous acyclovir-induced nephrotoxicity. Is pregnancy a risk factor?

(2020) J Boujenah et al.   Journal of Gynecology Obstetrics and Human Reproduction

A novel cascade strategy using a nanonized targeted prodrug for enhanced oral delivery efficiency

(2020) Meichen Guo et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Impact of obesity on acyclovir-induced nephrotoxicity

(2019) Katie E Barber et al.   Open Forum Infectious Diseases

The effect of amphiphilic N,N,N-trimethyl-O-octadecyl chitosan on the oral bioavailability of acyclovir

(2019) Hang Chen et al.   JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY

Impact of the implementation of a rapid meningitis/encephalitis multiplex polymerase chain reaction panel on IV acyclovir duration: multicenter, retrospective cohort of adult and pediatric patients

(2019) Martha Evans et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Comparing Treatment of Acute Retinal Necrosis With Either Oral Valacyclovir or Intravenous Acyclovir

(2018) Julijana Baltinas et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Semisolid self-microemulsifying drug delivery systems (SMEDDSs): Effects on pharmacokinetics of acyclovir in rats

(2018) Ljiljana Djekic et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Dissolving polymeric microneedle arrays for enhanced site-specific acyclovir delivery

(2018) Boonnada Pamornpathomkul et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

During the Emergency Department Evaluation of a Well-Appearing Neonate with Fever, Should Empiric Acyclovir Be Initiated?

(2018) Eric Bruno et al.   JOURNAL OF EMERGENCY MEDICINE

Incidence and predictors of intravenous acyclovir-induced nephrotoxicity

(2018) Rasmus K. B. Richelsen et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Valaciclovir therapy for herpes encephalitis: caution advised

(2018) Jacob Bodilsen et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The incidence, risk factors, and clinical outcomes of acute kidney injury (staged using the RIFLE classification) associated with intravenous acyclovir administration

(2018) Eun Ju Lee et al.   RENAL FAILURE

Functionalized PLA-PEG nanoparticles targeting intestinal transporter PepT1 for oral delivery of acyclovir

(2017) Betty Gourdon et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Prolonged acyclovir treatment in a child with opercular syndrome related to herpes simplex encephalitis

(2017) Arzu Karli et al.   Journal of Infection and Public Health

Pharmacokinetics of acyclovir in a morbidly obese patient with renal impairment

(2016) Tonya C. Smith et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Improving oral bioavailability of acyclovir using nanoparticulates of thiolated xyloglucan

(2016) Ashwini Madgulkar et al.   INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

Effect of permeability enhancers on paracellular permeability of acyclovir

(2016) Muge Ates et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

Herpes Simplex Encephalitis: Lack of Clinical Benefit of Long-term Valacyclovir Therapy

(2015) John W. Gnann et al.   CLINICAL INFECTIOUS DISEASES

Formulation and evaluation of nano based drug delivery system for the buccal delivery of acyclovir

(2015) Bandar E. Al-Dhubiab et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

Intravenous Acyclovir and Renal Dysfunction in Children: A Matched Case Control Study

(2015) Suchitra Rao et al.   JOURNAL OF PEDIATRICS

Improved Permeability of Acyclovir: Optimization of Mucoadhesive Liposomes Using the Phospholipid Vesicle-Based Permeation Assay

(2014) Elenaz Naderkhani et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Therapeutic Drug Monitoring of Continuous-Infusion Acylovir for Disseminated Herpes Simplex Virus Infection in a Neonate Receiving Concurrent Extracorporeal Life Support and Continuous Renal Replacement Therapy

(2014) Jeffrey J. Cies et al.   PHARMACOTHERAPY

Planar Microdevices for Enhanced In Vivo Retention and Oral Bioavailability of Poorly Permeable Drugs

(2014) Hariharasudhan D. Chirra et al.   Advanced Healthcare Materials

Acyclovir-resistant herpes simplex encephalitis in a patient treated with anti-tumor necrosis factor-α monoclonal antibodies

(2013) Kinda Schepers et al.   JOURNAL OF CLINICAL VIROLOGY

Differential Diagnosis of Central Nervous System Involvement in a Patient Treated With Acyclovir

(2013) Mia von Euler et al.   THERAPEUTIC DRUG MONITORING

Valacyclovir for Herpes Simplex Encephalitis

(2011) Thomas Pouplin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antiviral Drugs in Wastewater and Surface Waters: A New Pharmaceutical Class of Environmental Relevance?

(2010) Carsten Prasse et al.   ENVIRONMENTAL SCIENCE & TECHNOLOGY

Factors associated with delay to acyclovir administration in 184 patients with herpes simplex virus encephalitis

(2009) J. Poissy et al.   CLINICAL MICROBIOLOGY AND INFECTION

Ammonium methacrylate units polymer content and their effect on acyclovir colloidal nanoparticles properties and bioavailability in human volunteers

(2009) Ahmed H. Elshafeey et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

Acyclovir Liposomes for Intranasal Systemic Delivery: Development and Pharmacokinetics Evaluation

(2008) Ibrahim A. Alsarra et al.   DRUG DELIVERY

In Vitro Assessment of Acyclovir Permeation Across Cell Monolayers in the Presence of Absorption Enhancers

(2008) Pranav Shah et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Aciclovir

(2008) J. Arnal et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Liver targeting and anti-HBV activity of reconstituted HDL–acyclovir palmitate complex

(2007) M FENG   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS